Mesenchymal stromal cells from the foreskin: Tissue isolation, cell characterization and immunobiological properties.
BACKGROUND AIMS Because of their self renewal capacity, multilineage potential and immunomodulatory properties, MSCs are an attractive tool for cell based immunotherapy strategies. Foreskin, considered as a biological waste material, has been shown to be a reservoir of therapeutic cells. METHODS MSCs were isolated from different foreskin samples, maintained under in vitro culture and defined according to the International Society for Cellular Therapy (ISCT) criteria. We subsequently determined their main cell characteristics as well as their immunobiological properties. The following parameters were determined: (i) morphology and phenotype, (ii) proliferative and clonogenic potentials, (iii) tri lineage differentiation ability, (iv) immunological profile, (v) immunomodulatory properties and (vi) protein and messenger RNA expression/secretion profile of immunoregulatory cytokines/factors as well as the pattern of toll like receptors (TLRs) By using a pro inflammatory cytokine cocktail, we also evaluated the influence of an inflammatory environment on their biology. RESULTS With a typical fibroblast like morphology and an ISCT compliant phenotype, foreskin MSCs (FSK MSCs) were highly proliferative and had a great clonogenic potential. They displayed multilineage capacities and interesting immunomodulatory properties. Of importance, FSK MSCs were not immunogenetic and were further able to inhibit T cell proliferation. We showed that several immunoregulatory cytokines and factors might be potentially involved in FSK MSC immunomodulation with particular attention to hepatocyte growth factor and interleukin 11. Moreover, FSK MSCs expressed several TLRs and were sensitive to the inflammatory environment by properly adjusting their profile and fate. CONCLUSIONS Foreskin represents a new alternative source for MSCs that is compliant with ISCT criteria. Their unique immunobiological properties allow consideration of FSK MSCs as a valuable tolerogenic product for cell based immunotherapy.
Cytotherapy